Someone asking about an oral progesterone capsule may need a focused medicine discussion within a much broader menopause appointment. Gennev offers care from physicians and registered dietitian nutritionists, with prescriptions sent to a pharmacy when needed. The breadth is relevant, but it does not tell a reader what a particular capsule would contain or whether progesterone would be proposed.
This September 29, 2026 review evaluates Gennev’s service and published pricing information. It is a clinical-service assessment, not confirmation of a named oral product. No clinician encounter, pharmacy supply, insurance benefit or personal treatment response was tested.
In this article
The verified offer is clinical care rather than a capsule catalog
Gennev’s homepage describes virtual menopause appointments, medical history review and prescriptions when appropriate. Its pricing and care information identifies FDA-approved hormonal and nonhormonal treatment categories. Together they establish a relevant clinical service, without confirming an exact oral progesterone prescription.
The public records examined do not identify a manufacturer, capsule ingredient list or fixed medicine charge. That absence should remain visible in a review about capsules. Midi’s assessment provides a contrast because a separate Midi product page identifies a particular compounded preparation. Gennev should not be assigned that formulation, or any other provider’s product, merely because both services discuss menopause hormones.
An appointment can start with the intended role of each medicine
A Gennev physician reviews health history and symptoms before considering treatment, according to the service description. A focused progesterone question is what purpose the clinician would give that medicine within the proposed plan. It is reasonable to distinguish that purpose from a general desire to improve sleep, mood or overall wellbeing.
The progesterone-purpose guide explores that distinction. FDA information discusses why estrogen and an accompanying hormone may be considered together in relevant circumstances, as well as the risks that require professional assessment. The review does not decide whether someone needs that combination. A clear explanation should connect the named medicine to the person’s clinical situation rather than rely on a broad treatment category.
Physician time and dietitian time have separate functions and prices
Gennev’s published fee table lists self-pay doctor visits at $250 initially and $199 for follow-up. Dietitian visits are $199 initially and $119 afterward. Doctor appointments are described as thirty minutes; dietitian sessions have their own durations. These are charges for professional services, not prices for a box of progesterone.
The distinction matters when several parts of care are offered together. A nutrition discussion cannot replace the prescriber’s explanation of an intended medicine or the pharmacist’s review of its capsule ingredients. Ask which service is being booked, which other encounters are optional or recommended and how a medicine question will reach the appropriate professional. No bundled capsule-and-care total was established.
A prescription sent to the pharmacy still needs a product identity
The Gennev page describes same-day prescription transmission when needed. Sending an order does not establish that a particular pharmacy has the requested preparation, that a named brand is selected or that the product will be ready that day. Those are separate stages with information this review has not verified.
Ask what the prescription specifies and which label the pharmacy would provide. The capsule-excipient guide explains why the active hormone does not identify fillers, capsule materials or every allergy concern. MyMenopauseRx’s review examines a service whose public FAQ discusses pharmacy selection and changes more explicitly; those procedures cannot simply be assumed to apply to Gennev.
A known label is a comparison record, not a substitute label
The Prometrium labeling record describes an oral micronized progesterone capsule with peanut oil and gelatin, including a restriction for peanut allergy. It can illustrate the kind of product-specific information that matters. It does not establish that Gennev prescribes that brand, that a selected pharmacy would dispense it or that every progesterone capsule uses those ingredients.
If there is a concern about a particular substance, bring that concern into both the clinical and dispensing discussions. The answer should identify the preparation being considered and the relevant written information. Neither a general bioidentical description nor the absence of an ingredient list from a clinic website establishes that an eventual capsule is free of an allergen.
Sleep support and a medicine effect are not the same service
Gennev describes mindfulness, sleep and lifestyle support within its care model. Such support may coexist with a prescription, but it should not be mistaken for evidence that oral progesterone will improve a particular person’s sleep. The homepage’s patient recommendation and symptom-relief statements likewise do not isolate the effect of a capsule.
MedlinePlus discusses dizziness and drowsiness associated with oral progesterone. Our drowsiness questions help keep daily functioning and other medicines in the conversation. A patient can ask whom to contact about an unwanted effect and what information would help the clinician assess it. This review supplies no instruction to change the medicine or its timing.
Coverage and later contact need their own answers
The insurance information says visit coverage and the number of covered appointments depend on the plan. It describes an estimated patient share before care and a possible remaining balance after insurance processes the claim. A consultation estimate therefore does not establish a capsule’s pharmacy benefit, future visit allowance or final overall spending.
Cancellation and refund conditions were not established by these reviewed pages. The follow-up guide also encourages clarity about who handles later treatment and dispensing questions. Gennev’s documented service offers a route for clinical discussion; the unresolved oral-product details should be answered during that process, without turning broad access or satisfaction claims into proof of a preferred medicine.
Sources for this article
Source type matters. A provider page describes an offer; an exact product label describes that medicine.
- Gennev: virtual menopause careProvider physician and dietitian service; actual relevant prescribing, but no exact oral progesterone product or capsule formulary established · Checked 2026-09-29
- Gennev: insurance and pricingDated provider fee table and coverage process; doctor/dietitian initial/follow-up costs are separate from pharmacy charges · Checked 2026-09-28
- FDA: MenopauseCurrent federal patient guidance; product-dependent benefits/risks and prevention limits, no personal eligibility or class-wide label-change inference · Checked 2026-09-29
- DailyMed: Prometrium progesterone capsulesExact Acertis product labeling updated July23,2026; oral micronized progesterone, peanut oil/gelatin and peanut-allergy restriction, not a label for every provider or generic · Checked 2026-09-29
- MedlinePlus: ProgesteroneFederal medication information; oral-capsule identity, possible dizziness/drowsiness and professional discussion only; public schedules not reproduced as reader instructions · Checked 2026-09-29